Charles Schwab Investment Management Inc Erasca, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Erasca, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,762,696 shares of ERAS stock, worth $2.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,762,696

Previous 1,723,630 2.27%

Holding current value

$2.52 Million

Previous $4.71 Million 5.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$2.44 - $3.23 $95,321 - $126,183	39,066 Added 2.27%	1,762,696 $4.42 Million
Q3 2024 Nov 12, 2024	BUY	$2.17 - $3.28 $846,753 - $1.28 Million	390,209 Added 29.26%	1,723,630 $4.71 Million
Q2 2024 Aug 12, 2024	BUY	$1.79 - $2.63 $1.2 Million - $1.76 Million	669,551 Added 100.86%	1,333,421 $3.15 Million
Q1 2024 May 08, 2024	BUY	$1.67 - $2.55 $22,937 - $35,024	13,735 Added 2.11%	663,870 $1.37 Million
Q4 2023 Feb 06, 2024	BUY	$1.67 - $2.49 $14,188 - $21,155	8,496 Added 1.32%	650,135 $1.38 Million
Q3 2023 Nov 08, 2023	BUY	$1.97 - $2.91 $120,053 - $177,338	60,941 Added 10.49%	641,639 $1.26 Million
Q2 2023 Aug 09, 2023	BUY	$2.57 - $3.3 $81,237 - $104,313	31,610 Added 5.76%	580,698 $1.6 Million
Q1 2023 May 11, 2023	BUY	$2.74 - $4.44 $260,524 - $422,164	95,082 Added 20.94%	549,088 $1.65 Million
Q4 2022 Feb 13, 2023	BUY	$3.89 - $8.57 $24,238 - $53,399	6,231 Added 1.39%	454,006 $1.96 Million
Q3 2022 Nov 14, 2022	BUY	$5.82 - $10.68 $1.28 Million - $2.35 Million	220,194 Added 96.75%	447,775 $3.49 Million
Q2 2022 Aug 15, 2022	SELL	$4.58 - $8.72 $56,137 - $106,881	-12,257 Reduced 5.11%	227,581 $1.27 Million
Q1 2022 May 13, 2022	BUY	$8.6 - $15.48 $854,083 - $1.54 Million	99,312 Added 70.67%	239,838 $2.06 Million
Q4 2021 Feb 11, 2022	BUY	$12.51 - $22.75 $89,208 - $162,230	7,131 Added 5.35%	140,526 $2.19 Million
Q3 2021 Nov 16, 2021	BUY	$17.43 - $24.34 $2.33 Million - $3.25 Million	133,395 New	133,395 $2.83 Million

Others Institutions Holding ERAS

# of Institutions

153

Shares Held

227M

Call Options Held

10.9K

Put Options Held

65.1K

View Full List

About Erasca, Inc.

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $175M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

More about ERAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Erasca, Inc. Transaction History